The present invention is directed to racemic 1-(3,4-dichlorophenyl)-3-azab- icyclo[3.1.0]hexane, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, racemic 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and (+)-1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia, vasomotor symptoms (VMS) and chronic pain.

 
Web www.patentalert.com

< Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

< Method for treating nervous system disorders and conditions

> Novel spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors

> Memantine for the treatment of mild and mild to moderate Alzheimer's disease
~ 00233